Invention Grant
- Patent Title: Opioid receptor antagonist conjugate and use thereof
-
Application No.: US16074268Application Date: 2017-01-26
-
Publication No.: US11311533B2Publication Date: 2022-04-26
- Inventor: Mei He
- Applicant: SHANGHAI HANMAI BIO-PHARMA CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: SHANGHAI HANMAI BIO-PHARMA CO., LTD.
- Current Assignee: SHANGHAI HANMAI BIO-PHARMA CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: BakerHostetler
- Priority: CN201610072859.2 20160202
- International Application: PCT/CN2017/072727 WO 20170126
- International Announcement: WO2017/133634 WO 20170810
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61K47/60 ; A61P1/10 ; A61P23/00 ; A61K31/439 ; C07D489/08
Abstract:
The present invention relates to an opioid receptor antagonist conjugate and a use thereof. In particular, the present invention relates to a covalent coupling conjugate of a hydrophilic polymer and an opioid receptor antagonist and the use thereof.
Public/Granted literature
- US20210121455A1 OPIOID RECEPTOR ANTAGONIST CONJUGATE AND USE THEREOF Public/Granted day:2021-04-29
Information query
IPC分类:
